Cabaletta Bio Inc
Company Profile
Business description
Cabaletta Bio Inc is a clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies, and exploring their potential to provide a deep and durable, perhaps curative, treatment, for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes Chimeric AutoAntibody Receptor, or CAART cells that are designed to selectively bind and eliminate only specific B cells that produce disease-causing autoantibodies, or pathogenic B cells, while sparing normal B cells. Its CABA platform encompasses two strategies CARTA (chimeric antigen receptor T cells for autoimmunity) and CAART (chimeric autoantibody T cells) has the potential to be applied across a broad range of autoimmune diseases.
Contact
2929 Arch Street
Suite 600
Philadelphia PA 19104
USAT: +1 267 759-3100
E: investors@cabalettabio.com
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2024
Employees
138
Morningstar Investment Ideas
Stocks
ETFs
- Australian ETFs
- Active Australian Equity ETFs
- Passive Australian Equity ETFs
- Emerging Market Equity ETFs
- Sustainable ETFs
- Active Global Equity ETFs
- Passive Global Equity ETFs
- Active Australian Fixed Interest ETFs
- Passive Australian Fixed Interest ETFs
- Active Australian Listed Property ETFs
- Passive Australian Listed Property ETFs
- Active Global Fixed Interest ETFs
- Passive Global Fixed Interest ETFs
- Active Global Infrastructure ETFs
- Passive Global Infrastructure ETFs
- Active Global Property ETFs
- Passive Global Property ETFs
Funds
- Active Australian Equity Funds
- Passive Australian Equity Funds
- Active Global Equity Funds
- Passive Global Equity Funds
- Sustainable Funds
- Emerging Market Equity Funds
- Passive Australian Listed Property Funds
- Active Australian Listed Property Funds
- Passive Global Infrastructure Funds
- Active Global Infrastructure Funds
- Active Global Property Funds
- Passive Global Property Funds
- Active Australian Fixed Interest Funds
- Passive Australian Fixed Interest Funds
- Active Global Fixed Interest Funds
- Passive Global Fixed Interest Funds
Markets
Index
|
Last price
|
Change
|
% Change
|
---|---|---|---|
All Ordinaries | 8,361.20 | 20.10 | 0.24% |
CAC 40 | 7,512.09 | 62.65 | 0.84% |
DAX 40 | 18,776.47 | 143.36 | 0.77% |
Dow JONES (US) | 41,622.08 | 228.30 | 0.55% |
FTSE 100 | 8,342.93 | 64.49 | 0.78% |
HKSE | 17,660.02 | 237.90 | 1.37% |
NASDAQ | 17,592.13 | 91.85 | -0.52% |
Nikkei 225 | 36,203.22 | 378.54 | -1.03% |
NZX 50 Index | 12,671.95 | 32.44 | -0.26% |
S&P 500 | 5,633.09 | 7.07 | 0.13% |
S&P/ASX 200 | 8,140.90 | 19.30 | 0.24% |
SSE Composite Index | 2,704.09 | 13.03 | -0.48% |
Market Movers
Name
|
Last price
|
Change
|
% Change
|
---|---|---|---|
Telstra Group Ltd TLS | 4.02 | 0.01 | 0.25% |
Resolute Mining Ltd RSG | 0.72 | 0.01 | -0.69% |
Imugene Ltd IMU | 0.05 | 0.00 | -4.00% |
Pilbara Minerals Ltd PLS | 2.85 | 0.03 | -1.04% |
Red 5 Ltd RED | 0.33 | 0.01 | 1.54% |
Sayona Mining Ltd SYA | 0.02 | 0.00 | 0.00% |
Westgold Resources Ltd WGX | 2.67 | 0.09 | -3.26% |
South32 Ltd S32 | 3.23 | 0.06 | 1.89% |
Appen Ltd APX | 1.61 | 0.11 | 6.98% |
Core Lithium Ltd CXO | 0.10 | 0.00 | -3.06% |